Premier Anti-Aging Co., Ltd. provided consolidated earning guidance for the six months ending January 31, 2023 and full year ending July 31, 2023. For six months ending January 31, 2023, the company expects net sales of JPY 14,500 million, ordinary profit of JPY 20 million, loss attributable to owners of parent of JPY 60 million and basic loss per share of JPY 6.88.

For full year ending July 31, 2023, the company expects net sales of JPY 30,000 million, operating profit of JPY 1,500 million, ordinary profit of JPY 1,520 million, profit attributable to owners of parent of JPY 820 million and basic earnings per share of JPY 94.03.